Search results for " continuous" in Articles / App Notes

Article COVID-19 Diagnostics Supplier Ramps Up Production with Help of Cytiva’s Testa Center in Sweden
CONTINUE READING >> In this blog post, you can learn about how Solis BioDyne, Estonian manufacturer of polymerase chain reaction/quantitative polymerase chain reaction reagents to analyze DNA f…

Article Start-to-Finish Connected Manufacturing
Click here to learn more >> We understand that evaluating new biomanufacturing technologies that promise efficiency gains is challenging. That’s why we are demonstrating our mAb process that te…

Article Akron Bio Will Install a Cytiva FlexFactory to Manufacture Plasmid DNA
Cytiva will provide the first FlexFactory to be used in the manufacture of pDNA to Akron Bio. Cytiva will provide its FlexFactory, a flexible, single-use platform, to enable Akron Biotech to m…

Article A Small-Scale Model to Increase Yield in Cell Culture Perfusion of mAb at Large Scale
Click here to read more >> As process intensification is adopted into large-scale manufacturing, the responsibility on scale-down models to accurately represent the expanded operating space quick…

Article Reimagining Affordable Biosimilars
Advances in preclinical development play a crucial role in reducing cost for developing biosimilars.  By Anurag S. Rathore, Narendra Chirmule, and Himanshu Malani  Drug development is …

Article Cytiva Invests $500 Million Over 5 Years to Expand Global Capacity
The Uppsala plant is now fully automated with the latest technology to allow for continuous manufacturing. Other elements of the Uppsala investment include a capacity extension of Sephadex resin, whic…

Article Connected, Automated Downstream Process for mAb Screening and Evaluation
Click here to read more >> A pre-clinical lab is often faced with the need to constantly evaluate possible ways of increasing capacity and throughput. This study was done to show both proof of p…

Article Eliminating Residual Impurities Starts with a Strategic Plan
Eliminating Residual Impurities Starts with a Strategic Plan Identifying the source, assessing the risk, and removing residual impurities requires a strategic approach. By Cynthia A. Ch…

Article The Need for Advanced Process Modeling for New Therapeutic Biologics
The Need for Advanced Process Modeling for New Therapeutic BiologicsThe trend toward personalized medicines includes more complex manufacturing cycles that can benefit from advanced process modeling e…

Article Mapping a Route for Cell and Gene Therapy Process Development
…ilable downstream technologies, such as tangential flow filtration, counter-flow centrifugation, and continuous centrifugation methods. Importantly, the process control strategy could be diffe…

Show All Results

Previous PageNext Page